iBody
Latest round
- Series A
Last raised
- May 2018
Total raised
- $0.9M
Investors
- 1
About iBody
Established in 2018, and based in Aichi, Japan, iBody Inc. engages in the research and development of human monoclonal antibodies, as well as the screening of human and rabbit monoclonal antibodies. iBody’s unique Ecobody technology enables lightning-fast antibody expression and evaluation.
Who invested in iBody
1 investor across 1 round
See all investors in iBody
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 16, 2018
Amount
$0.9M
Investors
Questions about iBody
Who invested in iBody?
iBody has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iBody raised?
iBody has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iBody last raise money?
iBody's most recent round on record is a Series A, in May 2018.
What does iBody do?
Established in 2018, and based in Aichi, Japan, iBody Inc.
Where is iBody headquartered?
iBody is headquartered in Nagoya, Japan.
Which VCs invest in companies like iBody?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at iBody's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like iBody? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.